Cargando…
Repurposing of Antimicrobial Agents for Cancer Therapy: What Do We Know?
SIMPLE SUMMARY: Despite the leaps and bounds in the prevention and treatment of cancer, it remains the second leading cause of death worldwide. A significant hurdle during cancer treatment is the occurrence of intrinsic and acquired therapeutic resistance. This latter case emphasizes the need for ne...
Autores principales: | Pfab, Christina, Schnobrich, Luisa, Eldnasoury, Samir, Gessner, André, El-Najjar, Nahed |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8269327/ https://www.ncbi.nlm.nih.gov/pubmed/34206772 http://dx.doi.org/10.3390/cancers13133193 |
Ejemplares similares
-
Repurposing of Chronically Used Drugs in Cancer Therapy: A Chance to Grasp
por: Hijazi, Mohamad Ali, et al.
Publicado: (2023) -
Quasicrystals: What do we know? What do we want to know? What can we know?
por: Steurer, Walter
Publicado: (2018) -
What do we know and when do we know it?
por: Nicholls, Anthony
Publicado: (2008) -
Presbyopia: What We Do Know and What We Do Not Know in 2022
por: Grzybowski, Andrzej, et al.
Publicado: (2023) -
Vaginal Aging—What We Know and What We Do Not Know
por: Szymański, Jacek K., et al.
Publicado: (2021)